Autoimmune Disease Testing Market size was valued at USD 10.2 billion in 2022 and it is expected to be worth around USD 22.18 billion by 2030 growing at a remarkable GAGR of 10.2% over the forecast period 2023-2030.

The autoimmune disease testing market share is a rapidly growing sector in the healthcare industry. With the increasing prevalence of autoimmune diseases worldwide, there is a rising demand for accurate and efficient diagnostic tools to identify these conditions.

Autoimmune diseases occur when the body’s immune system mistakenly attacks its own healthy cells and tissues. These diseases can affect various organs and systems, including the skin, joints, muscles, blood vessels, and internal organs. Diagnosing autoimmune diseases can be challenging as their symptoms often overlap with other conditions, making it crucial to have reliable testing methods.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2986

In recent years, significant advancements have been made in autoimmune disease testing technologies. Traditional methods such as blood tests that measure specific antibodies or inflammation markers are still widely used. However, newer techniques like genetic testing and biomarker analysis are gaining prominence due to their ability to provide more accurate and personalized diagnoses.

KEY MARKET SEGMENTS

By Type

• Systemic autoimmune disease diagnostics
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Systemic Lupus Erythematosus (SLE)
  • Others
• Localized autoimmune disease diagnostics
  • Multiple sclerosis
  • Type 1 diabetes
  • Hashimoto’s Thyroiditis
  • Idiopathic thrombocytopenic purpura
  • Others

By End User

• Clinical laboratories
• Hospitals
• Other End users

Major Players Listed in the Report are as Follows:

Abbott, Trinity Biotech, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd, EUROIMMUN Medizinische Labordiagnostika AG, Siemens Healthcare GmbH, Danaher Corporation, Grifols, S.A., Oncimmune, HYCOR Biomedical Corporation and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),